Literature DB >> 3427227

Variations in lipoproteins during aminoglutethimide therapy.

J Bonneterre1, N Ghalim, M Nguyen, P Puchois, A Demaille, C Demarquilly, J C Fruchart.   

Abstract

Plasma lipids, apolipoproteins, and gamma-glutamyl-transpeptidase (GGT) were measured in 28 patients receiving aminoglutethimide (500 mg) and hydrocortisone (30 or 40 mg) for advanced breast cancer. A rise in cholesterol (CHOL), LDL-CHOL, apoprotein B, apoprotein CIII, and GGT was observed after 45 days. When the patients were divided in two groups according to lipid basal plasma levels, those with high CHOL and triglyceride did not experience any modification of lipid parameters (only GGT were elevated). Conversely normolipidaemic patients experienced an increase in CHOL, triglycerides, LDL-CHOL, apoproteins B and CIII, and GGT.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3427227     DOI: 10.1007/BF01810583

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

1.  Increased cholesterol biosynthesis following phenobarbital induced hypertrophy of agranular endoplasmic reticulum in liver.

Authors:  A L Jones; D T Armstrong
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

2.  Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day.

Authors:  J Bonneterre; H Coppens; L Mauriac; M Metz; J Rouesse; J P Armand; P Fargeot; M Mathieu; M Tubiana; P Cappelaere
Journal:  Eur J Cancer Clin Oncol       Date:  1985-10

3.  Aminoglutethimide-induced hypercholesterolaemia.

Authors:  J Bonneterre; M Nguyen; B Hecquet; P Cappelaere
Journal:  Lancet       Date:  1984-04-21       Impact factor: 79.321

4.  Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.

Authors:  M J Coyne; G G Bonorris; L I Goldstein; L J Schoenfield
Journal:  J Lab Clin Med       Date:  1976-02

5.  Quantitative determination of human plasma apolipoprotein A-II by a non competitive enzyme-linked immunosorbent assay.

Authors:  P Puchois; A Kandoussi; P Duriez; J C Fruchart; W J McConathy; E Koren
Journal:  J Immunoassay       Date:  1986

6.  [Aminoglutethimide-induced dyslipidemia. Experimental study].

Authors:  M Nguyen; J Bonneterre; J Vanlerenberghe; A Demaille
Journal:  Bull Cancer       Date:  1985       Impact factor: 1.276

7.  Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics.

Authors:  P V Luoma; E A Sotaniemi; A J Arranto
Journal:  Scand J Clin Lab Invest       Date:  1983-12       Impact factor: 1.713

8.  Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay.

Authors:  E Koren; P Puchois; W J McConathy; J D Fesmire; P Alaupovic
Journal:  Clin Chim Acta       Date:  1985-04-15       Impact factor: 3.786

9.  [Aminoglutethimide-induced dyslipemia. Clinical study].

Authors:  J Bonneterre; M Nguyen; B Hecquet; C Fournier; A Demaille
Journal:  Bull Cancer       Date:  1985       Impact factor: 1.276

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.